WNThigh colon cancer stem cells drive résistance to standard anti-angiogenic therapies

Autor: Cisarovsky, Christophe

Although chemotherapy combined with the anti-angiogenic, VEGF-blocking antibody bevacizumab is a first-line treatment for metastatic colorectal cancer (CRC) it provides only a modest survival benefit. In this work, we examined potential mechanisms dr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______1900::fd83fbbddcd31ac6f9946af317f5effb
https://serval.unil.ch/resource/serval:BIB_E367D5D12DF3.P001/REF.pdf

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Apelin-driven endothelial cell migration sustains intestinal progenitor cells and tumor growth.

Autor: Bernier-Latmani J; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland., Cisarovsky C; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland., Mahfoud S; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland., Ragusa S; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland., Dupanloup I; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Barras D; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland.; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Renevey F; Department of Biochemistry, University of Lausanne, Lausanne, Switzerland., Nassiri S; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, EPFL, Lausanne, Switzerland.; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Anderle P; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Squadrito ML; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, EPFL, Lausanne, Switzerland., Siegert S; Department of Biochemistry, University of Lausanne, Lausanne, Switzerland., Davanture S; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland., González-Loyola A; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland., Fournier N; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Luther SA; Department of Biochemistry, University of Lausanne, Lausanne, Switzerland., Benedito R; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain., Valet P; Institut RESTORE, UMR 1301-INSERM, 5070-CNRS, Université Paul Sabatier, Université de Toulouse, Toulouse, France., Zhou B; State Key Laboratory of Cell Biology, CAS Center for Excellence in Molecular Cell Science, Shanghai Institute of Biochemistry and Cell Biology, Chinese Academy of Sciences, Shanghai, China., De Palma M; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, EPFL, Lausanne, Switzerland., Delorenzi M; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland.; Bioinformatics Core Facility, SIB Swiss Institute of Bioinformatics, Lausanne, Switzerland., Sempoux C; Institute of Pathology, Lausanne University Hospital and University of Lausanne, Lausanne, Switzerland., Petrova TV; Department of Oncology, Ludwig Center for Cancer Research Lausanne and University of Lausanne, Lausanne, Switzerland.; Swiss Institute for Experimental Cancer Research (ISREC), School of Life Sciences, EPFL, Lausanne, Switzerland.

Publikováno v: Nature cardiovascular research [Nat Cardiovasc Res] 2022 May; Vol. 1 (5), pp. 476-490. Date of Electronic Publication: 2022 May 16.

[Breast cancer during pregnancy].

Autor: Schnetz M; Service d'oncologie médicale, Département d'oncologie, CHUV, 1011 Lausanne., Stravodimou A; Centre du sein, Département d'oncologie, CHUV, 1011 Lausanne., Cisarovsky C; Service d'oncologie médicale, Département d'oncologie, CHUV, 1011 Lausanne., Dunand A; Service de psychiatrie de liaison, Département d'oncologie, CHUV, 1011 Lausanne., Prior JO; Service de médecine nucléaire et imagerie moléculaire, Département de radiologie médicale, CHUV, 1011 Lausanne., Nicod Lalonde M; Service de médecine nucléaire et imagerie moléculaire, Département de radiologie médicale, CHUV, 1011 Lausanne., Baud D; Service d'obstétrique, Département femme-mère-enfant, CHUV, 1011 Lausanne., Meuwly JY; Service de radiodiagnostic et radiologie interventionnelle, Département de radiologie médicale, CHUV, 1011 Lausanne., Winterfeld U; Swiss Teratogen Information Service, Service de pharmacologie clinique, Département de médecine de laboratoire et pathologie, CHUV, 1011 Lausanne., Zaman K; Centre du sein, Département d'oncologie, CHUV, 1011 Lausanne.

Publikováno v: Revue medicale suisse [Rev Med Suisse] 2021 May 19; Vol. 17 (739), pp. 957-961.

[Management of peripheral neuropathy in the elderly].

Autor: Cisarovsky C; Service de médecine interne, CHUV, 1011 Lausanne., Nguyen S; Service de gériatrie et réadaptation gériatrique, CHUV, 1011 Lausanne., Vannotti M; Cabinet Lutrymed, FMH Médecine interne générale, Rue Verdaine 8A, 1095 Lutry., Büla C; Service de gériatrie et réadaptation gériatrique, CHUV, 1011 Lausanne., Kuntzer T; Service de neurologie, CHUV, 1011 Lausanne.

Publikováno v: Revue medicale suisse [Rev Med Suisse] 2019 Nov 06; Vol. 15 (670), pp. 2039-2043.